ibrutinib,zilovertamab
abbvie,oncternal therapeutics,janssen
[' ibru', 'zilovertamab', 'mantle,(-dismantle)', 'lymphoma']
zilovertamab is a humanized monoclonal antibody designed to inhibitor to tumor promoting activity of ror1. excited to see a future phase iii trial of zilovertamab + ibrutinib in pts with relapsed/refractory mantle cell lymphoma #ash22 
Heme/Onc Fellow @ClevelandClinic| Proud @PittTweet, @WakeForestMed and @OhioStateIMRes Alum| Opinions Are My Own| Most Tweets Will Involve Soccer